Wave Life Sciences Reports Q1 GAAP EPS of -$0.13, Revenue of $38.25M
Wave Life Sciences (WVE) reported Q1 GAAP EPS of -$0.13, which beat estimates by $0.19, and revenue of $38.25 million, surpassing expectations by $30.33 million. The company's revenue grew by 316.7% year-over-year. Cash and cash equivalents decreased to $544.6 million as of March 31, 2026, from $602.1 million as of December 31, 2025.
Tickers: $WVE
Topics: cash reserves earnings financial results GAAP EPS revenue